UK gov­ern­ment, pri­vate in­vestors dole out $340M+ to drug, di­ag­nos­tic man­u­fac­tur­ers

The gov­ern­ment of the Unit­ed King­dom is giv­ing out grants to sev­er­al man­u­fac­tur­ers that have a pres­ence in Eng­land, Wales and North­ern Ire­land.

The gov­ern­ment an­nounced that four com­pa­nies, in­clud­ing Ipsen, con­tract man­u­fac­tur­er Phar­maron, DNA man­u­fac­tur­er Touch­light and di­ag­nos­tic test pro­duc­er Ran­dox, will re­ceive a to­tal of £277 mil­lion ($341.1 mil­lion). Ac­cord­ing to a re­lease from the UK gov­ern­ment, this rep­re­sents the first por­tion of grants from the Life Sci­ences In­no­v­a­tive Man­u­fac­tur­ing Fund.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN